Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CD79B (Polatuzumab Biosimilar) Antikörper

Reaktivität: Human ELISA, FACS, BLI, Func, SPR Wirt: Human Monoclonal unconjugated Recombinant Antibody
Produktnummer ABIN7581312
  • Target
    CD79B (Polatuzumab Biosimilar)
    Antikörpertyp
    Recombinant Antibody
    Reaktivität
    Human
    Wirt
    • 1
    • 1
    Human
    Expressionssystem
    CHO Cells
    Klonalität
    • 2
    Monoklonal
    Konjugat
    • 2
    Dieser CD79B (Polatuzumab Biosimilar) Antikörper ist unkonjugiert
    Applikation
    ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
    Verwendungszweck
    Anti-CD79b Reference Antibody (polatuzumab)
    Sequenz
    EVQLVESGGG LVQPGGSLRL SCAASGYTFS SYWIEWVRQA PGKGLEWIGE ILPGGGDTNY NEIFKGRATF SADTSKNTAY LQMNSLRAED TAVYYCTRRV PIRLDYWGQG TLVTVSSAST KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSREEMTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK,DIQLTQSPSS LSASVGDRVT ITCKASQSVD YEGDSFLNWY QQKPGKAPKL LIYAASNLES GVPSRFSGSG SGTDFTLTIS SLQPEDFATY YCQQSNEDPL TFGQGTKVEI KRTVAAPSVF IFPPSDEQLK SGTASVVCLL NNFYPREAKV QWKVDNALQS GNSQESVTEQ DSKDSTYSLS STLTLSKADY EKHKVYACEV THQGLSSPVT KSFNRGEC
    Produktmerkmale
    Anti-CD79b Reference Antibody (polatuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
    Reinheit
    >95 %
    Isotyp
    IgG1
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Kommentare

    Therapeutic Agents by Target and Mechanism: CD79b inhibitors

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Konzentration
    1 mg/mL
    Buffer
    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
    Lagerung
    4 °C,-80 °C
    Informationen zur Lagerung
    +4°C,-80°C
  • Target
    CD79B (Polatuzumab Biosimilar)
    Substanzklasse
    Biosimilar
    Molekulargewicht
    145.5 kDa
    UniProt
    P40259
Sie sind hier:
Kundenservice